Citations

Citations to this article as recorded by  

• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
  Jihye Park, Jae Hee Cheon
  Gut and Liver.2018; 12(6): 623.     CrossRef

Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of UC taking into account currently available evidence and the expert opinion of the committee. Accurate diagnosis of UC requires thorough clinical, endoscopic, and histological assessment and careful exclusion of differential diagnoses, particularly infectious colitis. The goals of UC therapy are to induce and maintain remission, reduce the risk of complications, and improve quality of life. As outlined in the recommended treatment algorithm, choice of treatment is dictated by severity, extent, and course of disease. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to immunosuppressive treatment, especially with steroids and biologic agents, and should be regularly monitored for reactivation of latent infection. These consensus statements are also based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of UC in Taiwan.

Citations

Citations to this article as recorded by  

• Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
  Yingtong Chen, Xiaoyi Xu, Min Wang, Xiang Wang, Yan Wang, Yong Zhang, Jin Huang, Yuwen Tao, Wentao Fan, Lili Zhao, Li Liu, Zhining Fan
  Photodiagnosis and Photodynamic Therapy.2024; 48: 104220.     CrossRef
• High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
  Chen-Ta Yang, Hsu-Heng Yen, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang
  Scientific Reports.2024;[Epub]     CrossRef
• Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
  Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
  Intestinal Research.2024; 22(3): 213.     CrossRef
• Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan
  Hsu‐Heng Yen, Yu‐Chun Hsu, Chu‐Hsuan Kuo, Tsui‐Chun Hsu, Yang‐Yuan Chen
  Advances in Digestive Medicine.2023; 10(1): 28.     CrossRef
• Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
  Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
  Intestinal Research.2023; 21(1): 100.     CrossRef
• Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
  Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, Chia-Hung Tu, I-Che Feng, Ming-Jium Shieh, Chen-Shuan Chung, Hsu-Heng Yen, Jen-Wei Chou, Jau-Min Wong, Yu-Hwa Liu, Tien-Yu Huang, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, Feng-Fan Chiang, Chien-Yu Lu, Wen-Hung Hs
  Inflammatory Bowel Diseases.2023; 29(11): 1730.     CrossRef
• Health Maintenance and Preventative Care in Inflammatory Bowel Disease
  Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
  Journal of Clinical Gastroenterology.2023; 57(4): 325.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Association between ulcerative colitis and Helicobacter pylori infection: A case-control study
  Iyad Ali, Qusay Abdo, Shayma'a M. Al-Hihi, Ansam Shawabkeh
  Heliyon.2022; 8(2): e08930.     CrossRef
• Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
  Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
  Mingxiao Li, Rui Zhang, Mingjie Xin, Yi Xu, Shijia Liu, Boyang Yu, Boli Zhang, Jihua Liu
  Metabolites.2022; 12(10): 997.     CrossRef
• Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
  Shun-Wen Hsiao, Hsu-Heng Yen, Yang-Yuan Chen
  Gut and Liver.2022; 16(6): 840.     CrossRef
• Serum homocysteine level was elevated in ulcerative colitis and can be applied as diagnostic biomarker
  Xiaoping Zhang, Shanshan Wang, Hongmin Wang, Junxia Wu, Qihua Tan
  Pteridines.2022; 33(1): 87.     CrossRef
• Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
  Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
  Advances in Digestive Medicine.2021; 8(1): 40.     CrossRef
• Clinical features and treatment of inflammatory bowel disease in a low-incidence area
  Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
  Medicine.2021; 100(10): e25090.     CrossRef
• Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
  Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
• Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
  Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
  PLOS ONE.2021; 16(5): e0252286.     CrossRef
• Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
  Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
  Shaghayegh Baradaran Ghavami, Hamid Asadzadeh Aghdaei, Dario Sorrentino, Shabnam Shahrokh, Maryam Farmani, Fatemeh Ashrafian, Maria Pina Dore, Shahrbanoo Keshavarz Azizi Raftar, Seyed Mobin Khoramjoo, Mohammad Reza Zali
  International Journal of Molecular Sciences.2021; 22(15): 8274.     CrossRef
• Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
  Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
  World Chinese Journal of Digestology.2021; 29(15): 880.     CrossRef
• Association between Ulcerative Colitis and Helicobacter pylori Infection: A Case-Control Study
  Iyad Ali, Qusay Abdo, Shayma’a M. Al-Hihi, Ansam Shawabkeh
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• A case with cytomegalovirus colitis and toxic megacolon initially diagnosed as Crohn's disease
  Shan-Han Chang, Hsin-Yun Sun, Chia-Tung Shun, Shu-Chen Wei
  Journal of the Formosan Medical Association.2020; 119(9): 1442.     CrossRef
• Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
  Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
  Digestive and Liver Disease.2020; 52(8): 869.     CrossRef
• Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
  Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
  PeerJ.2020; 8: e9537.     CrossRef
• Ulcerative colitis
  Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin-Biroulet, Toshifumi Hibi
  Nature Reviews Disease Primers.2020;[Epub]     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• To assess the effective and safety of berberine hydrochloride in ulcerative colitis
  Yong Zhang, Jin Wang, Daorui Hou, Shuguang Yan, Sijie Dang
  Medicine.2020; 99(49): e23482.     CrossRef
• Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
  Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118(7): 1083.     CrossRef
• Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
  Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2019; 17(1): 54.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response
  Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Tzu-Chi Hsu, Horng-Yuan Wang
  Medicine.2019; 98(21): e15748.     CrossRef
• Ulcerative Colitis in Elderly People: An Emerging Issue
  Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Chen-Wang Chang
  International Journal of Gerontology.2018;[Epub]     CrossRef
• Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
  Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
  Intestinal Research.2018; 16(4): 599.     CrossRef
• Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo‐Controlled Trial
  Xiaofan Chen, Heyun Nie, Wenjun Liu, Xu Zhou, Jianhua Nie, Bin Xie, Dongping Chen, Yiping Jiang, Kunhe Zhang, Ying Fu, Deping Yang, Yan Xiong, Zhangyang Zhao, Xin Sun, Weifeng Zhu, Carmen Mannucci
  Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
• Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis
  Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Cheng-Hsin Chu, Shou-Chuan Shih, Tzu-Chi Hsu, Horng-Yang Wang, John Green
  PLOS ONE.2017; 12(12): e0189377.     CrossRef

Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.

Citations

Citations to this article as recorded by  

• Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
  Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
  Intestinal Research.2024; 22(3): 250.     CrossRef
• Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study
  Nai‐Yu Chen, Chiao‐Hsiung Chuang, Yu‐Ching Chang, Yea‐Huei Kao Yang, Peng‐Hsu Chen, Ching‐Lan Cheng
  Clinical Pharmacology & Therapeutics.2023; 114(4): 914.     CrossRef
• Health Maintenance and Preventative Care in Inflammatory Bowel Disease
  Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
  Journal of Clinical Gastroenterology.2023; 57(4): 325.     CrossRef
• Negative pressure wound management in perineal wound status post abdominoperineal resection and extralevator abdominoperineal excision: a meta-analysis and trial sequential analysis
  Cheng-Wei Fan, Po-Huang Chen, Hong-Jie Jhou, Yi-Chiao Cheng
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak Evidence
  Simcha Weissman, Muhammad Aziz, Matthew R. Baniqued, Mohamed Ahmed, Sameh Elias, Joseph D. Feuerstein, James H. Tabibian
  Journal of Gastrointestinal Cancer.2022; 53(3): 669.     CrossRef
• Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
  Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
  Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
  Advances in Digestive Medicine.2021; 8(1): 40.     CrossRef
• Clinical features and treatment of inflammatory bowel disease in a low-incidence area
  Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
  Medicine.2021; 100(10): e25090.     CrossRef
• Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument
  Haixin Cheng, Ziyin Ma, Boran Yu, Xiaohui Liu, Chao Tian, Xuli Zhong, Libo Zhao
  Journal of Clinical Pharmacy and Therapeutics.2021; 46(4): 1155.     CrossRef
• Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
  Yuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Chien-Hsing Lin, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Jen-Kou Lin
  Cancers.2021; 13(8): 1883.     CrossRef
• Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)
  
  Journal of Digestive Diseases.2021; 22(6): 298.     CrossRef
• Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
  Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
  PLOS ONE.2021; 16(5): e0252286.     CrossRef
• Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
  Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Clinical significance of granulomas in Crohn's disease: A systematic review and meta‐analysis
  Seung Wook Hong, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim
  Journal of Gastroenterology and Hepatology.2020; 35(3): 364.     CrossRef
• Diagnostic efficacy of double-balloon enteroscopy in patients with suspected isolated small bowel Crohn’s disease
  Zihan Huang, Xiang Liu, Fei Yang, Guoxin Wang, Nan Ge, Sheng Wang, Jintao Guo, Siyu Sun
  BMC Gastroenterology.2020;[Epub]     CrossRef
• Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
  Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
  Digestive and Liver Disease.2020; 52(8): 869.     CrossRef
• Strengthened monitoring and optimized management of Crohn’s disease patients
  Jing-Jing Wang, Yi-Hong Fan, Rong Huang
  World Chinese Journal of Digestology.2020; 28(15): 660.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice
  Sona Gancarcikova, Stanislav Lauko, Gabriela Hrckova, Zuzana Andrejcakova, Vanda Hajduckova, Marian Madar, Livia Kolesar Fecskeova, Dagmar Mudronova, Kristina Mravcova, Gabriela Strkolcova, Radomira Nemcova, Jana Kacirova, Andrea Staskova, Stefan Vilcek,
  Cells.2020; 9(12): 2571.     CrossRef
• Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
  Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118(7): 1083.     CrossRef
• Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
  Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2019; 17(1): 54.     CrossRef
• Response to Chamberlin and Borody
  Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs, Miguel D. Regueiro, Bruce E. Sands
  American Journal of Gastroenterology.2019; 114(1): 171.     CrossRef
• Immunogenicity of biologic therapies: causes and consequences
  Wolf-Henning Boehncke, Nicolo Costantino Brembilla
  Expert Review of Clinical Immunology.2018; 14(6): 513.     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
  Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu
  Arthritis Research & Therapy.2018;[Epub]     CrossRef
• Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn’s Disease
  Hsu-Heng Yen, Chen-Wang Chang, Jen-Wei Chou, Shu-Chen Wei
  Clinical Endoscopy.2017; 50(5): 417.     CrossRef

Intestinal Behçet's disease (BD), generally accepted as a type of inflammatory bowel disease (IBD), could be diagnosed when patients with BD have objectively documented gastrointestinal symptoms and intestinal ulcerations. Similar to IBD, intestinal BD has an unpredictable disease course with relapse and remission and is often related to a poor prognosis. However, there is no single gold standard for assessment of the disease activity of intestinal BD, and its diagnosis and management depend heavily on expert opinions. The Korean IBD Study Group recently developed novel diagnostic criteria based on colonoscopy findings and clinical manifestations using a modified Delphi process to overcome drawbacks of previously used consensus for the diagnosis of intestinal BD. In addition, the recently developed disease activity index for intestinal BD, consisting of a relatively simple 8-point index, could also help in determining treatment strategies and monitoring therapeutic responses. In this review, the progress in the diagnosis and disease activity measurement of intestinal BD will be discussed.

Citations

Citations to this article as recorded by  

• Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study
  Xiaoman Zu, Shanshan Xiong, Yaming Lu, Ning Zhang, Shu Xu, Rui Feng, Baili Chen, Zhirong Zeng, Minhu Chen, Yao He
  Clinical Therapeutics.2024; 46(3): 201.     CrossRef
• Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
  Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
• Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients
  Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 276.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis
  Qingfeng Zhang, Chunyan Ma, Rongrong Dong, Weizhen Xiang, Meiqi Li, Zhenzhen Ma, Qingrui Yang
  Yonsei Medical Journal.2022; 63(2): 148.     CrossRef
• Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet’s disease: Case report and the review of literature
  Takashi Onaka, Kazuhisa Nakano, Yuri Uemoto, Naoto Miyakawa, Yasuyuki Otsuka, Aiko Ogura-Kato, Fumie Iwai, Yoshiya Tanaka, Akihito Yonezawa
  Modern Rheumatology Case Reports.2022; 6(2): 273.     CrossRef
• ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging Appearance of Gastrointestinal Behcet’s Disease
  Burak İnce, Ali Kibar, Sertaç Asa, Rabia Lebriz Uslu Beşli, Muhammet Sait Sağer, Ahmet Emre Eşkazan, Ali İbrahim Hatemi, Gülen Hatemi, Kerim Sönmezoğlu
  Molecular Imaging and Radionuclide Therapy.2022; 31(1): 57.     CrossRef
• Clinical Course of Patients with Intestinal Behçet’s Disease According to Consensus-Based Diagnostic Categories
  Yu Young Joo, Bo-In Lee, Seung-Jun Kim, Han Hee Lee, Jin Su Kim, Jae Myung Park, Young-Seok Cho, Kang Moon Lee, Sang Woo Kim, Hwang Choi, Myung-Gyu Choi
  Gut and Liver.2022; 16(5): 746.     CrossRef
• Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behçet’s Disease with Intestinal Involvement and Crohn’s Disease
  Fatma Alibaz-Oner, Rabia Ergelen, Ilkay Ergenc, Gizem Seven, Ayten Yazıcı, Ayse Cefle, Cemal Bes, Ozlen Atug, Haner Direskeneli
  Digestive Diseases and Sciences.2021; 66(8): 2750.     CrossRef
• Deep‐learning system for real‐time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis
  Jung Min Kim, Jun Gu Kang, Sungwon Kim, Jae Hee Cheon
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2141.     CrossRef
• Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
  Jihye Park, Daeun Jeong, Youn Wook Chung, Seunghan Han, Da Hye Kim, Jongwook Yu, Jae Hee Cheon, Ji-Hwan Ryu
  Scientific Reports.2021;[Epub]     CrossRef
• Behçet syndrome
  Yusuf Yazici, Gulen Hatemi, Bahram Bodaghi, Jae Hee Cheon, Noburu Suzuki, Nicola Ambrose, Hasan Yazici
  Nature Reviews Disease Primers.2021;[Epub]     CrossRef
• C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
  Eun Ae Kang, Jung Won Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Min Soo Cho, Jae Hee Cheon
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
  Yehyun Park, Jae Hee Cheon
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report
  Yu Chen, Huanjun Huang, Yao He, Minhu Chen, Ursula Seidler, De'an Tian, Fang Xiao
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20
  Yu Chen, Zhenghao Ye, Liping Chen, Tingting Qin, Ursula Seidler, De'an Tian, Fang Xiao
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Behсet's disease: intestinal damage
  R. G. Goloeva, Z. S. Alekberova
  Rheumatology Science and Practice.2019; 56(6): 767.     CrossRef
• Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab
  Zhe Yan, Bei-Bei Cui, Yong-Yang Yu, Geng Yin, Xiao-Min Cen, Qi-Bing Xie
  Medicine.2019; 98(9): e14624.     CrossRef
• Intestinal manifestations of Behçet's disease
  R G Goloeva, Z S Alekberova, T A Lisitsyna, E A Stepanova, L P Orlova
  Terapevticheskii arkhiv.2019; 91(5): 111.     CrossRef
• Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
  Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
  Gut and Liver.2018; 12(4): 433.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef

Behçet's disease (BD) is a chronic relapsing disease involving multiple organ systems. BD is characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmological, neurological, and/or gastrointestinal manifestations. It is widely recognized that the presence of intestinal lesions may be a poor prognostic factor in intestinal BD, increasing the risk of surgery and decreasing the quality of life. Despite this, the management of intestinal BD has not been standardized. Empirical therapies including 5-aminosalicylic acid and corticosteroids have been used anecdotally to treat intestinal BD, but recent studies have provided evidence for the efficacy of anti-tumor necrosis factor α monoclonal antibodies. The development of agents targeting tumor necrosis factor α continues, it seems likely that they will change the therapeutic strategy and clinical outcomes of intestinal BD and inflammatory bowel disease. Monitoring disease activity such as endoscopic evaluation will become more important to obtain better outcomes. Here, we review current and future perspectives in the treatment and outcomes of intestinal BD.

Citations

Citations to this article as recorded by  

• Behçet's syndrome
  Giacomo Emmi, Alessandra Bettiol, Gülen Hatemi, Domenico Prisco
  The Lancet.2024; 403(10431): 1093.     CrossRef
• Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
  Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  European Journal of Gastroenterology & Hepatology.2024; 36(4): 445.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Behçet disease: epidemiology, classification criteria and treatment modalities
  Alia Fazaa, Yasmine Makhlouf, Faiza Ben Massoud, Saoussen Miladi, Hiba Boussaa, Kmar Ouenniche, Leila Souebni, Selma Kassab, Selma Chekili, Kawther Ben Abdelghani, Ahmed Laatar
  Expert Review of Clinical Immunology.2024; : 1.     CrossRef
• Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
  So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(2): 111.     CrossRef
• Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
  Yoki Furuta, Ryosuke Gushima, Hideaki Naoe, Munenori Honda, Yuiko Tsuruta, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama, Nahoko Fujimoto, Shinya Hirata, Eiko Miyagawa, Komei Sakata, Yumiko Mizuhashi, Mikako Iwakura, Masayuki Murai, Masao Matsuoka
  Journal of Clinical Medicine.2023; 12(9): 3131.     CrossRef
• Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
  Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
  Journal of Gastroenterology and Hepatology.2023;[Epub]     CrossRef
• Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
  Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Vineet Ahuja
  JGH Open.2022; 6(2): 100.     CrossRef
• Mucosal healing in intestinal Behçet's disease: A systematic review and meta‐analysis
  Liang Gong, Yue Lun Zhang, Lu Xi Sun, Guo Rong Chen, Dong Wu
  Journal of Digestive Diseases.2021; 22(2): 83.     CrossRef
• Experimental Therapeutic Solutions for Behcet’s Disease
  Burçin Cansu Bozca, Erkan Alpsoy
  Journal of Experimental Pharmacology.2021; Volume 13: 127.     CrossRef
• Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach
  Erkan Alpsoy, Pietro Leccese, Giacomo Emmi, Shigeaki Ohno
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Behçet Disease: An Update for Dermatologists
  Erkan Alpsoy, Burcin Cansu Bozca, Asli Bilgic
  American Journal of Clinical Dermatology.2021; 22(4): 477.     CrossRef
• Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
  Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
  Intestinal Research.2021; 19(3): 301.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease
  Mari Hayashida, Jun Miyoshi, Tatsuya Mitsui, Miki Miura, Daisuke Saito, Akihito Sakuraba, Soko Kawashima, Noriko Ikegaya, Kazuhito Fukuoka, Miho Karube, Yoshinori Komagata, Shinya Kaname, Annabelle A Okada, Shunji Fujimori, Minoru Matsuura, Tadakazu Hisam
  Journal of Gastroenterology and Hepatology.2020; 35(8): 1340.     CrossRef
• Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease
  H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim
  Zeitschrift für Rheumatologie.2020; 79(7): 702.     CrossRef
• Update on the treatment of Behçet’s syndrome
  Sinem Nihal Esatoglu, Gulen Hatemi
  Internal and Emergency Medicine.2019; 14(5): 661.     CrossRef
• Behсet's disease: intestinal damage
  R. G. Goloeva, Z. S. Alekberova
  Rheumatology Science and Practice.2019; 56(6): 767.     CrossRef
• Intestinal manifestations of Behçet's disease
  R G Goloeva, Z S Alekberova, T A Lisitsyna, E A Stepanova, L P Orlova
  Terapevticheskii arkhiv.2019; 91(5): 111.     CrossRef
• The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim
  Clinical Rheumatology.2018; 37(7): 1913.     CrossRef
• Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
  Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
  Gut and Liver.2018; 12(4): 433.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• Small Bowel Lesions Mimicking Crohn’s Disease
  David B. Sachar
  Current Gastroenterology Reports.2018;[Epub]     CrossRef
• Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
  Jihye Park, Jae Hee Cheon
  Gut and Liver.2018; 12(6): 623.     CrossRef

Citations

Citations to this article as recorded by  

• Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
  Motoki Makuuchi, Yoichi Kakuta, Junji Umeno, Toshimitsu Fujii, Tetsuya Takagawa, Takashi Ibuka, Miki Miura, Yu Sasaki, Sakuma Takahashi, Hiroshi Nakase, Hiroki Kiyohara, Keiichi Tominaga, Yosuke Shimodaira, Sakiko Hiraoka, Nobuhiro Ueno, Shunichi Yanai, T
  Journal of Gastroenterology.2024; 59(6): 468.     CrossRef
• Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study
  Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• A systematic review of aspects of NUDT15 pharmacogenomic variants and thiopurine-induced myelosuppression
  Rachel Palmer, Jaime Peters
  RPS Pharmacy and Pharmacology Reports.2024;[Epub]     CrossRef
• m6A modification in inflammatory bowel disease provides new insights into clinical applications
  Jiamin Zhang, Bimei Song, Yue Zeng, Chao Xu, Liang Gao, Yan Guo, Jingbo Liu
  Biomedicine & Pharmacotherapy.2023; 159: 114298.     CrossRef
• Targeting FTO by Dac51 contributes to attenuating DSS-induced colitis
  Chunyan Peng, Chang Zheng, Fan Zhou, Ying Xie, Lei Wang, Deyan Chen, Xiaoqi Zhang
  International Immunopharmacology.2023; 116: 109789.     CrossRef
• Single-Nucleotide Polymorphisms, c.415C > T (Arg139Cys) and c.416G > A (Arg139His), in the NUDT15 Gene Are Associated with Thiopurine-Induced Leukopenia
  Tetsuichiro Isono, Daiki Hira, Yoshito Ikeda, Masahiro Kawahara, Satoshi Noda, Atsushi Nishida, Osamu Inatomi, Noriki Fujimoto, Akira Andoh, Tomohiro Terada, Shin-ya Morita
  Biological and Pharmaceutical Bulletin.2023; 46(3): 412.     CrossRef
• Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia
  Minu Singh, Divya Bhaskar, Prateek Bhatia, Rozy Thakur, Pankaj Sharma, Deepak Bansal, Richa Jain, Amita Trehan
  Cancer Chemotherapy and Pharmacology.2023; 92(1): 51.     CrossRef
• Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review
  Devendra Desai, Anuraag Jena, Vishal Sharma, Toshifumi Hibi
  Expert Review of Clinical Pharmacology.2023; 16(7): 643.     CrossRef
• Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials
  Anuraag Jena, Chhagan L Birda, Arup Choudhury, Vishal Sharma
  Expert Opinion on Drug Safety.2023; 22(12): 1253.     CrossRef
• Comparative assessment of anti-cancer drugs against NUDT15 variants to prevent leucopenia side effect in leukemia patients
  V. Janakiraman, M. Sudhan, Khalaf F. Alsharif, Ibrahim F. Halawani, Shiek S.S.J. Ahmed, Shankargouda Patil
  Journal of Genetic Engineering and Biotechnology.2023; 21(1): 82.     CrossRef
• A rare case of Azathioprine-induced leukopenia in an European woman
  Wautier Séverine, De Koninck Xavier, Coche Jean-Charles
  Acta Clinica Belgica.2022; 77(1): 163.     CrossRef
• NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine
  Kanyarat Khaeso, Patcharee Komvilaisak, Su-on Chainansamit, Nontaya Nakkam, Kunanya Suwannaying, Pitchayanan Kuwatjanakul, Keiko Hikino, Areerat Dornsena, Sirimas Kanjanawart, Napat Laoaroon, Suda Vannaprasaht, Takeshi Taketani, Wichittra Tassaneeyakul
  Drug Metabolism and Pharmacokinetics.2022; 43: 100436.     CrossRef
• Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population
  Xin-Hui Khoo, Shin Yee Wong, Nik Razima Wan Ibrahim, Ruey Terng Ng, Kee Seang Chew, Way Seah Lee, Zhi Qin Wong, Raja Affend Raja Ali, Shahreedhan Shahrani, Alex Hwong-Ruey Leow, Ida Normiha Hilmi
  Frontiers in Medicine.2022;[Epub]     CrossRef
• NUDT15Genotyping in Thiopurine Drug Therapy
  Jong Kwon Lee, Rihwa Choi, Soo-Youn Lee
  Laboratory Medicine Online.2022; 12(4): 217.     CrossRef
• Personalized medicine to implementation science: Thiopurines set for the leap
  Vishal Sharma, Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(10): 651.     CrossRef
• Pharmacogenetic determinants of thiopurines in an Indian cohort
  Shaik Mohammad Naushad, Mekala Janaki Ramaiah, Vijay Kumar Kutala, Tajamul Hussain, Salman A. Alrokayan
  Pharmacological Reports.2021; 73(1): 278.     CrossRef
• The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
  Xinwei Xu, Jintu Huang, Dickson Kofi Wiredu Ocansey, Yuxuan Xia, Zihan Zhao, Zhiwei Xu, Yongmin Yan, Xu Zhang, Fei Mao
  Journal of Inflammation Research.2021; Volume 14: 3289.     CrossRef
• Importance of NUDT15 Polymorphisms in Thiopurine Treatments
  Yoichi Tanaka, Yoshiro Saito
  Journal of Personalized Medicine.2021; 11(8): 778.     CrossRef
• Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease
  Kang Chao, Yibiao Huang, Xia Zhu, Jian Tang, Xueding Wang, Lang Lin, Huili Guo, Caibin Zhang, Miao Li, Qingfan Yang, Jie Huang, Lingna Ye, Pinjin Hu, Min Huang, Qian Cao, Xiang Gao
  Alimentary Pharmacology & Therapeutics.2021; 54(9): 1124.     CrossRef
• Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
  Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su-on Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• High-resolution melt analysis enables simple genotyping of complicated polymorphisms of codon 18 rendering the NUDT15 diplotype
  Yoichi Kakuta, Yasuhiro Izumiyama, Daisuke Okamoto, Takeru Nakano, Ryo Ichikawa, Takeo Naito, Rintaro Moroi, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Hisashi Shiga, Hisaaki Kudo, Naoko Minegishi, Yosuke Kawai, Katsushi Tokunaga, Masao Nagasaki,
  Journal of Gastroenterology.2020; 55(1): 67.     CrossRef
• An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients
  Sylvia Chen, Wei Zhi Tan, Natalia Sutiman, Cindy Lim, Sze Sing Lee, Wai Fook Leong, Madeline Tjai, Chunyan Wang, Chris San Choon Kong, Sai Wei Chuah, Brian John Schwender, Webber Chan, Hang Hock Shim, Wee Chian Lim, Chiea Chuen Khor, Khoon Lin Ling, Balra
  The Pharmacogenomics Journal.2020; 20(3): 505.     CrossRef
• Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia
  Yue Zhou, Li Wang, Xiao‐Ying Zhai, Li Wen, Fang Tang, Fan Yang, Xi‐Ting Liu, Lei Dong, Li‐Juan Zhi, Hai‐Yan Shi, Guo‐Xiang Hao, Yi Zheng, Evelyne Jacqz‐Aigrain, Tian‐You Wang, Wei Zhao
  British Journal of Clinical Pharmacology.2020; 86(8): 1519.     CrossRef
• NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
  Katsuyoshi Matsuoka
  Intestinal Research.2020; 18(3): 275.     CrossRef
• Long‐term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine
  Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, Shunsuke Hamada, Mikiko Shimizu, Kosaku Nanki, Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Shinya Sugimoto, Yasushi Iwao, Haruhiko Ogata, Tadakazu Hisamatsu, Makoto Naganuma, Maiko Motobayashi, Kohei Suz
  Journal of Gastroenterology and Hepatology.2019; 34(10): 1751.     CrossRef
• Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBD
  Sara van Gennep, Kadère Konté, Berrie Meijer, Martijn W. Heymans, Geert R. D’Haens, Mark Löwenberg, Nanne K. H. de Boer
  Alimentary Pharmacology & Therapeutics.2019; 50(5): 484.     CrossRef
• Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease
  Shintaro Terashita, Tomomi Tanaka, Hiromichi Taneichi, Yuichi Adachi, Masaaki Mori
  Pediatrics International.2019; 61(9): 920.     CrossRef
• Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8
  Hao Yin, Yun Song, Meimei Zheng, Ju Han, Jiyou Tang
  Frontiers in Neurology.2019;[Epub]     CrossRef
• Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
  Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa
  Journal of Gastroenterology.2018; 53(2): 172.     CrossRef
• NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
  Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya, Hirotake Sakuraba, Atsushi Nishida, Shoko Nakagawa, Miki Miura, Takahiko Toyonaga, Kei Onodera, Masaru Shinozaki, Yoh Ishiguro, Shinta Mizuno, Masahiro Takahara, Shunichi Yanai
  Journal of Gastroenterology.2018; 53(9): 1065.     CrossRef
• Severe thiopurine‐induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case–control study
  Mari Kishibe, Hiroyoshi Nozaki, Mizue Fujii, Shin Iinuma, Sawa Ohtsubo, Satomi Igawa, Kyoko Kanno, Masaru Honma, Kan Kishibe, Kensaku Okamoto, Akemi Ishida‐Yamamoto
  The Journal of Dermatology.2018; 45(10): 1160.     CrossRef
• Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis
  Sarah Cargnin, Armando A. Genazzani, Pier Luigi Canonico, Salvatore Terrazzino
  Pharmacological Research.2018; 135: 102.     CrossRef
• A single‐center experience with methotrexate in the treatment of Chinese Crohn’s disease patients
  Tian Rong Wang, Yu Qi Qiao, Duo Wu Zou, Zhi Hua Ran
  Journal of Digestive Diseases.2018; 19(12): 753.     CrossRef

Citations

Citations to this article as recorded by  

• Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017
  Chung Sang Tse, Chien-Hsiang Weng, Michelle Kwon, Courtney Benjamin Wolk, Lily A Brown, Kanika Malani, Samir A Shah, Sean D Fine
  Inflammatory Bowel Diseases.2024; 30(1): 150.     CrossRef
• Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity
  Seung Yong Shin, Hee Sung Kim, Kisung Kim, Chang Won Choi, Jung Min Moon, Jeong Wook Kim, Hyun Jin Joo, Jeongkuk Seo, Muhyeon Sung, Chang Hwan Choi
  The Korean Journal of Internal Medicine.2024; 39(1): 68.     CrossRef
• Patient experiences in ulcerative colitis: conceptual model and review of patient-reported outcome measures
  Chong Kim, Fiona L. Brown, Caroline Burk, Milena Anatchkova, Nashmel Sargalo, Ankita Kaushik
  Quality of Life Research.2024; 33(5): 1373.     CrossRef
• Colonic Dysregulation of Major Metabolic Pathways in Experimental Ulcerative Colitis
  Ji Yeon Noh, Naser Farhataziz, Michael T. Kinter, Xin Yan, Yuxiang Sun
  Metabolites.2024; 14(4): 194.     CrossRef
• A Phenomenological Investigation of Trauma in 18 Adults Living With Inflammatory Bowel Disease
  Heidi Glynn, Simon R. Knowles
  Clinical Nursing Research.2023; 32(1): 159.     CrossRef
• Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases
  Johanna Holman, Molly Hurd, Peter L. Moses, Gary M. Mawe, Tao Zhang, Suzanne L. Ishaq, Yanyan Li
  The Journal of Nutritional Biochemistry.2023; 113: 109238.     CrossRef
• Medical consultation in ulcerative colitis: Key elements for improvement
  Yago González-Lama, Elena Ricart, Ana Cábez, Pilar Fortes, Susana Gómez, Francesc Casellas
  World Journal of Gastroenterology.2023; 29(6): 917.     CrossRef
• The relationship of major depressive disorder with Crohn's disease activity
  Carolina Bortolozzo Graciolli Facanali, Carlos Walter Sobrado Junior, Renério Fraguas Junior, Marcio Roberto Facanali Junior, Lucas Rodrigues Boarini, Lucas Faraco Sobrado, Ivan Cecconello
  Clinics.2023; 78: 100188.     CrossRef
• Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
  Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(9): 541.     CrossRef
• The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review
  Elizabeth Dent, Nicola Davinson, Stephanie Wilkie
  Applied Psychology: Health and Well-Being.2022; 14(2): 626.     CrossRef
• Ilex rotunda Thunb Protects Against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Restoring the Intestinal Mucosal Barrier and Modulating the Oncostatin M/Oncostatin M Receptor Pathway
  Yao Li, Xu Yang, Jia-ni Yuan, Rui Lin, Yun-yuan Tian, Yu-xin Li, Yan Zhang, Xu-fang Wang, Yan-hua Xie, Si-wang Wang, Xiao-hui Zheng
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care
  Nosheen Umar, Dominic King, Joht Singh Chandan, Neeraj Bhala, Krish Nirantharakumar, Nicola Adderley, Dawit T. Zemedikun, Phil Harvey, Nigel Trudgill
  Alimentary Pharmacology & Therapeutics.2022; 56(5): 814.     CrossRef
• Association of inflammatory bowel disease with suicidal ideation, suicide attempts, and suicide: A systematic review and meta-analysis
  Qin Xiong, Fuyou Tang, Yilin Li, Fengjiao Xie, Lei Yuan, Chengjiao Yao, Ruike Wu, Juan Wang, Qiuxiang Wang, Peimin Feng
  Journal of Psychosomatic Research.2022; 160: 110983.     CrossRef
• Modelling symptoms to suicide risk in individuals with inflammatory bowel disease
  Valentina Mihajlovic, Dean A Tripp, Jill A Jacobson
  Journal of Health Psychology.2021; 26(12): 2143.     CrossRef
• Risk of Inflammatory Bowel Disease Following Appendectomy in Adulthood
  Wei-Sheng Chung, Sunny Chung, Chung-Y Hsu, Cheng-Li Lin
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
  P. Thomson, P. Núñez, R. Quera, C. Bay
  New Microbes and New Infections.2021; 42: 100898.     CrossRef
• Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Jooyoung Lee, Jong Pil Im, Kyungdo Han, Jihye Kim, Hyun Jung Lee, Jaeyoung Chun, Joo Sung Kim
  Gut and Liver.2020; 14(1): 89.     CrossRef
• Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management
  G. Pellino, D. S. Keller, G. M. Sampietro, V. Annese, M. Carvello, V. Celentano, C. Coco, F. Colombo, N. Cracco, F. Di Candido, M. Franceschi, S. Laureti, G. Mattioli, L. Pio, G. Sciaudone, G. Sica, V. Villanacci, R. Zinicola, S. Leone, S. Danese, A. Spin
  Techniques in Coloproctology.2020; 24(2): 105.     CrossRef
• Inflammatory bowel disease fatigue: an analysis of definitions, risk factors and impact and their implications for assessment and management
  Doireann Ni Dhalaigh, Anna Marie Greaney, Dawn Farrell
  Gastrointestinal Nursing.2020; 18(5): 42.     CrossRef
• Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea
  Jung Rock Moon, Chang Kyun Lee, Sung Noh Hong, Jong Pil Im, Byong Duk Ye, Jae Myung Cha, Sung-Ae Jung, Kang-Moon Lee, Dong Il Park, Yoon Tae Jeen, Young Sook Park, Jae Hee Cheon, Hyesung Kim, BoJeong Seo, Youngdoe Kim, Hyo Jong Kim
  Gut and Liver.2020; 14(4): 459.     CrossRef
• Consensus document on the management preferences of patients with ulcerative colitis: points to consider and recommendations
  Francesc Casellas, Daniel Guinard Vicens, Santiago García-López, Yago González-Lama, Federico Argüelles-Arias, Manuel Barreiro-de Acosta, Laura Marín Sánchez, Juan Manuel Mendive, Roberto Saldaña, Ana Cabez, Susana Gómez, Estíbaliz Loza
  European Journal of Gastroenterology & Hepatology.2020; 32(12): 1514.     CrossRef
• Preconception Care Program for Women with Inflammatory Bowel Disease Using Intervention Mapping: A Protocol for Program Development
  Young Jin Lee, Yeon Hee Kim, Hae Won Kim
  International Journal of Environmental Research and Public Health.2020; 17(24): 9365.     CrossRef
• Herbs-partitioned moxibustion alleviates aberrant intestinal epithelial cell apoptosis by upregulating A20 expression in a mouse model of Crohn’s disease
  Jing Zhou, Lu-Yi Wu, Liu Chen, Ya-Jing Guo, Yi Sun, Tao Li, Ji-Meng Zhao, Chun-Hui Bao, Huan-Gan Wu, Yin Shi
  World Journal of Gastroenterology.2019; 25(17): 2071.     CrossRef
• EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
  María Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, José Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar
  Therapeutic Advances in Gastroenterology.2019; 12: 175628481984703.     CrossRef
• Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy
  Zili Lin, Huiyi Wu, Yiming Fu, Shixue Dai
  Inflammatory Bowel Diseases.2019; 25(12): 1886.     CrossRef
• Analysis of the Nutrients and Food Products Intake of Polish Males with Ulcerative Colitis in Remission
  Dominika Głąbska, Dominika Guzek, Gustaw Lech
  Nutrients.2019; 11(10): 2333.     CrossRef
• Are there also negative effects of social support? A qualitative study of patients with inflammatory bowel disease
  Alexander Palant, Wolfgang Himmel
  BMJ Open.2019; 9(1): e022642.     CrossRef
• Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis
  Lina Carvalho, Joana R. M. Gomes, Ludgero C. Tavares, Ana R. Xavier, Karel D. Klika, Rikard Holmdahl, Rui A. Carvalho, M. Margarida Souto-Carneiro
  Frontiers in Immunology.2018;[Epub]     CrossRef
• Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile
  Antonia Fernández, Daniela Simian, Rodrigo Quera, Lilian Flores, Patricio Ibáñez, Jaime Lubascher, Carolina Figueroa, Udo Kronberg, Gonzalo Pizarro, Daniela Fluxá
  Complementary Therapies in Medicine.2018; 40: 77.     CrossRef
• IBD2020 global forum: results of an international patient survey on quality of care
  Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray, Simon PL Travis
  Intestinal Research.2018; 16(4): 537.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef

Citations

Citations to this article as recorded by  

• A kizárólagos enteralis táplálás hazai gyakorlata gyermekkori Crohn-betegségben
  Kriszta Katinka Boros, Veronika Kovács, Éva Nemes, Orsolya Kadenczki, Gábor Veres, Katalin Eszter Müller
  Orvosi Hetilap.2024; 165(26): 1002.     CrossRef
• Enteral Nutrition Prescription in Children and Adults with Inflammatory Bowel Diseases: Gaps in Current Gastroenterology Practice in Saudi Arabia
  Sarah M. Ajabnoor, Atheer Attar, Noof BinJahlan, Nawal Almutairi, Shimaa Bashmail, Almoutaz Hashim, Alastair Forbes, Hani Jawa
  Nutrients.2023; 15(1): 232.     CrossRef
• Implementation of exclusive enteral nutrition in pediatric patients with Crohn’s disease—results of a survey of CEDATA-GPGE reporting centers
  Sarah Peters, Serdar Cantez, Jan De Laffolie
  Molecular and Cellular Pediatrics.2022;[Epub]     CrossRef
• Global attitudes on and the status of enteral nutrition therapy for pediatric inflammatory bowel disease
  Juan Luo, Yong-Mei Xie, Mei Wu, Jin-Gui Zhao, Liang-Liang Hu
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Elemental Diet Enriched with Amino Acids Alleviates Mucosal Inflammatory Response and Prevents Colonic Epithelial Barrier Dysfunction in Mice with DSS-Induced Chronic Colitis
  Di Guo, Jun Yang, Fangmei Ling, Lei Tu, Junrong Li, Yidong Chen, Kaifang Zou, Liangru Zhu, Xiaohua Hou
  Journal of Immunology Research.2020; 2020: 1.     CrossRef
• Exclusive enteral nutrition in children with inflammatory bowel disease: Physician perspectives and practice
  Shaun S C Ho, Andrew S Day
  JGH Open.2019; 3(2): 148.     CrossRef
• Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease
  Morgan Lawley, Jessica W. Wu, Victor M. Navas‐López, Hien Q. Huynh, Matthew W. Carroll, Min Chen, Pavel Medvedev, Andrew S. Day, Séamus Hussey, Rotem Sigall‐Boneh, Arie Levine, Eytan Wine
  Journal of Pediatric Gastroenterology and Nutrition.2018;[Epub]     CrossRef
• Living on Liquids: Surviving and Thriving on Exclusive Enteral Nutrition
  Kelly Issokson
  American Journal of Gastroenterology.2017; 112(10): 1491.     CrossRef

Citations

Citations to this article as recorded by  

• ATHEROSCLEROTIC CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
  Ondřej Kučerka, Martin Malý, Petra Mináriková, Jan M. Horáček
  Military Medical Science Letters.2024;[Epub]     CrossRef
• Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors
  Kashif Rahim, Muhammad Shan, Ihtisham Ul Haq, Muhammad Nawaz, Sajida Maryam, Mansour Alturki, Abdulaziz Al Khzem, Kamel Metwally, Simona Cavalu, Saleh Alqifari, Galal Yahya
  Journal of Inflammation Research.2024; Volume 17: 1897.     CrossRef
• Interaction between diet and genetics in patients with inflammatory bowel disease
  Daniéla Oliveira Magro, Ligia Yukie Sassaki, Júlio Maria Fonseca Chebli
  World Journal of Gastroenterology.2024; 30(12): 1644.     CrossRef
• Quantitative urinary proteome analysis reveals potential biomarkers for disease activity of Behcet’s disease uveitis
  Weiwei Qin, Anyi Liang, Xiaoxu Han, Meifen Zhang, Youhe Gao, Chan Zhao
  BMC Ophthalmology.2024;[Epub]     CrossRef
• Dietary fat induced chylomicron-mediated LPS translocation in a bicameral Caco-2cell model
  Monic M. M. Tomassen, Coen Govers, A. Paul Vos, Nicole J. W. de Wit
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Endothelial Glycocalyx Preservation—Impact of Nutrition and Lifestyle
  Paula Franceković, Lasse Gliemann
  Nutrients.2023; 15(11): 2573.     CrossRef
• Toll-like Receptors and Cytokine Modulation by Goat Milk Extracellular Vesicles in a Model of Intestinal Inflammation
  Chiara Grazia De Ciucis, Floriana Fruscione, Livia De Paolis, Samanta Mecocci, Susanna Zinellu, Lisa Guardone, Giulia Franzoni, Katia Cappelli, Elisabetta Razzuoli
  International Journal of Molecular Sciences.2023; 24(13): 11096.     CrossRef
• Longitudinal flux balance analyses of a patient with episodic colonic inflammation reveals microbiome metabolic dynamics
  Arianna Basile, Almut Heinken, Johannes Hertel, Larry Smarr, Weizhong Li, Laura Treu, Giorgio Valle, Stefano Campanaro, Ines Thiele
  Gut Microbes.2023;[Epub]     CrossRef
• Hyperimmune bovine colostrum containing lipopolysaccharide antibodies (IMM124-E) has a nondetrimental effect on gut microbial communities in unchallenged mice
  Rachele Gore, Mitra Mohsenipour, Jennifer L. Wood, Gayathri K. Balasuriya, Elisa L. Hill-Yardin, Ashley E. Franks, Manuela Raffatellu
  Infection and Immunity.2023;[Epub]     CrossRef
• MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients
  Frida Gorreja, Charles Caër, Stephen T. A. Rush, Sophia K. Forsskål, Anetta Härtlova, Maria K. Magnusson, Elinor Bexe Lindskog, Lars G. Börjesson, Mattias Block, Mary Jo Wick
  Inflammation.2022; 45(4): 1631.     CrossRef
• Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
  Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao, Jixin Zhong
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Genetic Deletion of LRP5 and LRP6 in Macrophages Exacerbates Colitis-Associated Systemic Inflammation and Kidney Injury in Response to Intestinal Commensal Microbiota
  Indumathi Manoharan, Daniel Swafford, Arulkumaran Shanmugam, Nikhil Patel, Puttur D. Prasad, Riyaz Mohamed, Qingqing Wei, Zheng Dong, Muthusamy Thangaraju, Santhakumar Manicassamy
  The Journal of Immunology.2022; 209(2): 368.     CrossRef
• The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review
  Francisco Jorge Melo, Pedro Pinto-Lopes, Maria Manuela Estevinho, Fernando Magro
  Inflammatory Bowel Diseases.2021; 27(7): 1153.     CrossRef
• Effects of Anthocyanin on Intestinal Health: A Systematic Review
  Thaísa Agrizzi Verediano, Hércia Stampini Duarte Martino, Maria Cristina Dias Paes, Elad Tako
  Nutrients.2021; 13(4): 1331.     CrossRef
• Anti-inflammatory activity of Jasminum grandiflorum L. subsp. floribundum (Oleaceae) in inflammatory bowel disease and arthritis models
  Riham A. El-Shiekh, Dorria Hussein, Attia H. Atta, Samar M. Mounier, Mohamed R. Mousa, Essam Abdel-Sattar
  Biomedicine & Pharmacotherapy.2021; 140: 111770.     CrossRef
• Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
  Jasmijn A. M. Sleutjes, Jeanine E. Roeters van Lennep, C. Janneke van der Woude, Annemarie C. de Vries
  Therapeutic Advances in Gastroenterology.2021; 14: 175628482110321.     CrossRef
• Phase angle through electrical bioimpedance as a predictor of cellularity in inflammatory bowel disease
  Sabrina A Fernandes, Carina Rossoni, Vivian W Koch, Marcello Imbrizi, Rosana Evangelista-Poderoso, Letícia Pereira Pinto, Daniéla Oliveira Magro
  Artificial Intelligence in Gastroenterology.2021; 2(4): 111.     CrossRef
• Correlation between Antibodies to Bacterial Lipopolysaccharides and Barrier Proteins in Sera Positive for ASCA and ANCA
  Aristo Vojdani, Elroy Vojdani, Martha Herbert, Datis Kharrazian
  International Journal of Molecular Sciences.2020; 21(4): 1381.     CrossRef
• CD26/DPP4 - a potential biomarker and target for cancer therapy
  Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester, Wolfgang Jungraithmayr
  Pharmacology & Therapeutics.2019; 198: 135.     CrossRef
• Is there a possible correlation between antibodies against lipopolysaccharide, intestinal and blood-brain barrier proteins in IBD subjects?
  Aristo Vojdani
  Autoimmunity Reviews.2019; 18(6): 639.     CrossRef
• CD26 in autoimmune diseases: The other side of “moonlight protein”
  Yunjuan Zhao
  International Immunopharmacology.2019; 75: 105757.     CrossRef
• Remission in Crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
  Daniéla Oliveira Magro, Andrey Santos, Dioze Guadagnini, Flavia Moreira de Godoy, Sylvia Helena Monteiro Silva, Wilson José Fernandes Lemos, Nicola Vitulo, Sandra Torriani, Lilian Vital Pinheiro, Carlos Augusto Real Martinez, Mario José Abdalla Saad, Clau
  Scientific Reports.2019;[Epub]     CrossRef
• Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults
  Tiansheng Wang, Jeff Y. Yang, John B. Buse, Virginia Pate, Huilin Tang, Edward L. Barnes, Robert S. Sandler, Til Stürmer
  Diabetes Care.2019; 42(11): 2065.     CrossRef
• Emerging concepts in non-invasive monitoring of Crohn’s disease
  Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis
  Therapeutic Advances in Gastroenterology.2018; 11: 175628481876907.     CrossRef
• VISCERAL FAT IS INCREASED IN INDIVIDUALS WITH CROHN’S DISEASE: A COMPARATIVE ANALYSIS WITH HEALTHY CONTROLS
  Daniéla Oliveira MAGRO, Maria Rita Lazzarini BARRETO, Everton CAZZO, Michel Gardere CAMARGO, Paulo Gustavo KOTZE, Claudio Saddy Rodrigues COY
  Arquivos de Gastroenterologia.2018; 55(2): 142.     CrossRef

Citations

Citations to this article as recorded by  

• A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation
  Masahiro Kishi, Fumihito Hirai, Noritaka Takatsu, Takashi Hisabe, Yasumichi Takada, Tsuyoshi Beppu, Ken Takeuchi, Makoto Naganuma, Kazuo Ohtsuka, Kenji Watanabe, Takayuki Matsumoto, Motohiro Esaki, Kazutaka Koganei, Akira Sugita, Keisuke Hata, Kitarou Fut
  Journal of Gastroenterology.2022; 57(4): 246.     CrossRef
• Inflammatory Bowel Disease – Non-biological treatment
  Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho
  Pharmacological Research.2020; 160: 105075.     CrossRef
• Systematic review: safety of mesalazine in ulcerative colitis
  P. Sehgal, J.‐F. Colombel, A. Aboubakr, N. Narula
  Alimentary Pharmacology & Therapeutics.2018; 47(12): 1597.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef

Citations

Citations to this article as recorded by  

• Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database
  Takumi Ota, Takahiro Takebe, Yutaka Shimizu, Takashi Orido, Hiroyuki Tanaka, Shiro Nakamura
  Digestion.2024; 105(3): 232.     CrossRef
• Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S‐methyltransferase inhibition
  Hiromu Morikubo, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Satoshi Kuronuma, Osamu Takeuchi, Tenyo Shiba, Hiroki Kiyohara, Mao Matsubayashi, Shintaro Sagami, Masaru Nakano, Osamu Ikezaki, Tadakazu Hisamatsu, Yoichi Tanaka, Toshifumi Hibi
  Journal of Gastroenterology and Hepatology.2021; 36(8): 2116.     CrossRef
• Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis
  Tong Wang, Hua Lu, Fangyuan Li, Qi Zhang
  Medicine.2021; 100(5): e23915.     CrossRef
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
  Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
  Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
• Efficacy of Multi Matrix System Mesalazine for the Induction of Remission in Patients with Ulcerative Colitis who Insufficiently Respond toother Mesalazine Formulations: A Japanese Single-center Study
  Masaki Kato, Kohei Sugiyama, Maki Miyakawa, Masanao Nasuno, Hiroki Tanaka, Satoshi Motoya
  Nippon Daicho Komonbyo Gakkai Zasshi.2021; 74(6): 357.     CrossRef
• pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)
  Helmut Deissler, Heinrich Krammer, Anton Gillessen
  Biomedical Reports.2021;[Epub]     CrossRef
• Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
  Hiroshi Nakase
  Gut and Liver.2020; 14(1): 7.     CrossRef
• Inflammatory Bowel Disease – Non-biological treatment
  Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho
  Pharmacological Research.2020; 160: 105075.     CrossRef
• Systematic review: safety of mesalazine in ulcerative colitis
  P. Sehgal, J.‐F. Colombel, A. Aboubakr, N. Narula
  Alimentary Pharmacology & Therapeutics.2018; 47(12): 1597.     CrossRef

Citations

Citations to this article as recorded by  

• Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
  Yakup Kilic, Shahed Kamal, Farah Jaffar, Danujan Sriranganathan, Mohammed Nabil Quraishi, Jonathan P Segal
  Inflammatory Bowel Diseases.2024; 30(2): 230.     CrossRef
• Isoliquiritin Ameliorates Ulcerative Colitis in Rats through Caspase 3/HMGB1/TLR4 Dependent Signaling Pathway
  Zhiwei Miao, Mingjia Gu, Faisal Raza, Hajra Zafar, Jianyi Huang, Yuhang Yang, Muhammad Sulaiman, Jing Yan, Yi Xu
  Current Gene Therapy.2024; 24(1): 73.     CrossRef
• Use of Systemic Steroids for Inflammatory Bowel Disease Can Increase Intraocular Pressure
  Amrik Gil, Madeline Alizadeh, Daniel Yarmovsky, Ramya Swamy, Uni Wong
  Gastro Hep Advances.2024; 3(4): 536.     CrossRef
• Ocular lesions in patients with ulcerative colitis
  Antonina V. Varvarynets, Valerii D. Beliayev, Mykhailo M. Hechko, Artur V. Kurakh
  Wiadomości Lekarskie.2024; 77(3): 445.     CrossRef
• The risk for ophthalmological conditions in ulcerative colitis: A population‐based case–control study. Is silica dust‐exposure associated with inflammatory eye disease?
  Karim Makdoumi, Lucyn Ayoub, Ing‐Liss Bryngelsson, Pål Graff, Pernilla Wiebert, Per Vihlborg
  Acta Ophthalmologica.2024;[Epub]     CrossRef
• Optical coherence tomography angiography findings of retinal vascular structures in children with celiac disease
  Ishak Isik, Lutfiye Yaprak, Asli Yaprak, Ulas Akbulut
  Journal of American Association for Pediatric Ophthalmology and Strabismus.2022; 26(2): 69.e1.     CrossRef
• Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era
  Alix Cuny, Lucas Guillo, Cédric Baumann, Patrick Netter, Silvio Danese, Bénédicte Caron, Laurent Peyrin-Biroulet, Karine Angioi
  Journal of Clinical Medicine.2022; 11(15): 4538.     CrossRef
• The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
  Jing-Xing Li, Chun-Chi Chiang, San-Ni Chen, Jane-Ming Lin, Yi-Yu Tsai
  International Journal of Environmental Research and Public Health.2022; 19(23): 15683.     CrossRef
• Ocular Manifestations of Inflammatory Bowel Disease
  Janaki Shah, Aaditya Shah, Lynn Hassman, Alexandra Gutierrez
  Inflammatory Bowel Diseases.2021; 27(11): 1832.     CrossRef
• Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists
  Fabio CASTELLANO, Giovanni ALESSIO, Carmela PALMISANO
  Minerva Gastroenterology.2021;[Epub]     CrossRef
• The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
  Dominika Jakubczyk, Katarzyna Leszczyńska, Sabina Górska
  Nutrients.2020; 12(7): 1973.     CrossRef
• Les manifestations oculaires au cours de la maladie de Crohn
  D. Saadouli, K. Ben Mansour, M. Farae, I. Loukil, S. Yahyaoui, M.A. El Afrit
  Journal Français d'Ophtalmologie.2020; 43(10): 1025.     CrossRef
• Evaluation of Objective Signs and Subjective Symptoms of Dry Eye Disease in Patients with Inflammatory Bowel Disease
  Zsolt Barta, Levente Czompa, Aniko Rentka, Eva Zold, Judit Remenyik, Attila Biro, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray, Adam Kemeny-Beke
  BioMed Research International.2019; 2019: 1.     CrossRef
• The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
  Ana Luiza Biancardi, Leandro Lopes Troncoso, Haroldo Vieira de Moraes Jr, Cyrla Zaltman
  Intestinal Research.2019; 17(1): 153.     CrossRef
• Current clinical issue of skin lesions in patients with inflammatory bowel disease
  Tomoya Iida, Tokimasa Hida, Minoru Matsuura, Hisashi Uhara, Hiroshi Nakase
  Clinical Journal of Gastroenterology.2019; 12(6): 501.     CrossRef
• Manifestaciones extraintestinales de enfermedad inflamatoria intestinal
  Amaranta Luzoro, Pablo Sabat, Leonardo Guzmán, Francisca Frias
  Revista Médica Clínica Las Condes.2019; 30(4): 305.     CrossRef
• Corneal Manifestations of Inflammatory Bowel Disease
  Levente Czompa, Zsolt Barta, Hassan Ziad, Gabor Nemeth, Aniko Rentka, Zsuzsa Aszalos, Eva Zold, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray, Adam Kemeny-Beke
  Seminars in Ophthalmology.2019; 34(7-8): 543.     CrossRef

Citations

Citations to this article as recorded by  

• Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study
  Joyce W Y Mak, Sun Yang, Annalise Stanley, Xiaoqing Lin, Mark Morrison, Jessica Y L Ching, Junkun Niu, Amy L Wilson‐O'Brien, Rui Feng, Whitney Tang, Amy L Hamilton, Leo Or, Gina L Trakman, Winnie Y Y Lin, Joseph J Y Sung, Ming Hu Chen, Yinglei Mao, Michae
  JGH Open.2022; 6(6): 369.     CrossRef
• Does the road to primary prevention of inflammatory bowel disease start from childhood?
  Saurabh Kedia, Vineet Ahuja
  JGH Open.2022; 6(6): 365.     CrossRef
• Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis
  Junfeng Zou, Chen Liu, Shu Jiang, Dawei Qian, Jinao Duan, Anthony R. Richardson
  Infection and Immunity.2021;[Epub]     CrossRef
• Factors Affecting Ulcerative Colitis Flare-Ups: Associations With Smoking Habits and Other Patient Characteristics
  Nadim H Malibary, Mohammed A Ezzat, Ahmed M Mogharbel, Khalid A Kouzaba, Abdulaziz A Alkadi, Usama H Malki, Sultan M Gharib, Faisal M Altowairqi, Omar I Saadah, Mahmoud H Mosli
  Cureus.2021;[Epub]     CrossRef
• Inflammatory bowel disease: An Indian perspective
  Mayank Jain, Jayanthi Venkataraman
  Indian Journal of Medical Research.2021; 153(4): 421.     CrossRef
• Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior
  Rupa Banerjee, Partha Pal, Susan Hutfless, B Girish Ganesh, D Nageshwar Reddy
  Intestinal Research.2019; 17(4): 486.     CrossRef
• Decreased Breg/Th17 Ratio Improved the Prognosis of Patients with Ulcerative Colitis
  Xue Bing, Liang Linlang, Chen Keyan
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• Is the emergence of inflammatory bowel disease a prime example of “the third epidemiological transition”?
  Saurabh Kedia, Vineet Ahuja
  Indian Journal of Gastroenterology.2018; 37(3): 183.     CrossRef

Citations

Citations to this article as recorded by  

• Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus
  Masaaki Uehara, Shinya Matsushita, Satsuki Aochi, Motohisa Yamamoto
  Modern Rheumatology Case Reports.2023; 7(1): 68.     CrossRef
• Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
  Shun Fujiwara, Ami Kawamoto, Maiko Motobayashi, Shuji Hibiya, Kento Takenaka, Hiromichi Shimizu, Eiko Saito, Toshimitsu Fujii, Masakazu Nagahori, Daisuke Kawata, Natsuka Umezawa, Tadashi Hosoya, Shinsuke Yasuda, Kazuo Ohtsuka, Ryuichi Okamoto
  DEN Open.2023;[Epub]     CrossRef
• Treatment Options in Pediatric Behçet’s Disease
  Teresa Giani, Angela Flavia Luppino, Giovanna Ferrara
  Pediatric Drugs.2023; 25(2): 165.     CrossRef
• Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
  Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim
  Gut and Liver.2023; 17(5): 777.     CrossRef
• Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
  Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon
  BMC Gastroenterology.2023;[Epub]     CrossRef
• The efficacy and safety of anti‐tumor necrosis factor agents in the treatment of intestinal Behcet's disease, a systematic review and meta‐analysis
  Mengyuan Zhang, Jinjing Liu, Tingting Liu, Wei Han, Xiaoyin Bai, Gechong Ruan, Hong Lv, Huijun Shu, Yue Li, Ji Li, Bei Tan, Weiyang Zheng, Hui Xu, Wenjie Zheng, Hong Yang, Jiaming Qian
  Journal of Gastroenterology and Hepatology.2022; 37(4): 608.     CrossRef
• Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
  Haruka Miyazaki, Daisuke Watanabe, Norihiro Okamoto, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Namiko Hoshi, Makoto Ooi, Yuzo Kodama
  BMC Gastroenterology.2022;[Epub]     CrossRef
• New insights on multigenic autoinflammatory diseases
  Petros Efthimiou, Olga Petryna, Priscila Nakasato, Apostolos Kontzias
  Therapeutic Advances in Musculoskeletal Disease.2022; 14: 1759720X2211178.     CrossRef
• Anti-TNF-α agents for refractory intestinal Behçet’s disease: case series and meta-analysis
  Shukai Zhan, Caiguang Liu, Na Li, Tong Li, Zhenyi Tian, Min Zhao, Dongxuan Wu, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang
  Therapeutic Advances in Gastroenterology.2022; 15: 175628482211166.     CrossRef
• Clinical Manifestations and Management of Pediatric Behçet’s Disease
  Ya-Chiao Hu, Bor-Luen Chiang, Yao-Hsu Yang
  Clinical Reviews in Allergy & Immunology.2021; 61(2): 171.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Mucosal healing in intestinal Behçet's disease: A systematic review and meta‐analysis
  Liang Gong, Yue Lun Zhang, Lu Xi Sun, Guo Rong Chen, Dong Wu
  Journal of Digestive Diseases.2021; 22(2): 83.     CrossRef
• Experimental Therapeutic Solutions for Behcet’s Disease
  Burçin Cansu Bozca, Erkan Alpsoy
  Journal of Experimental Pharmacology.2021; Volume 13: 127.     CrossRef
• Advances in the Treatment of Behcet’s Disease
  Fatma Alibaz-Oner, Haner Direskeneli
  Current Rheumatology Reports.2021;[Epub]     CrossRef
• Behçet Disease: An Update for Dermatologists
  Erkan Alpsoy, Burcin Cansu Bozca, Asli Bilgic
  American Journal of Clinical Dermatology.2021; 22(4): 477.     CrossRef
• Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
  Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
  Intestinal Research.2021; 19(3): 301.     CrossRef
• Juvenile-onset Behçet's syndrome and mimics
  Clare E. Pain
  Clinical Immunology.2020; 214: 108381.     CrossRef
• Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
  Yehyun Park, Jae Hee Cheon
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• An Overview of Conventional and Recent Treatment Options for Behcet’s Disease
  Kader Cetin Gedik, Micol Romano, Roberta A. Berard, Erkan Demirkaya
  Current Treatment Options in Rheumatology.2020; 6(2): 99.     CrossRef
• Safety of systemic treatments for Behçet’s syndrome
  Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini, Florenzo Iannone
  Expert Opinion on Drug Safety.2020; 19(10): 1269.     CrossRef
• The Efficacy of Medium- to Long-term Anti-TNF-α Antibody-based Maintenance Therapy in Behçet's Disease Patients with Intestinal Lesions
  Harutaka Kambayashi, Teppei Omori, Satomi Saito, Shun Murasugi, Hiroyuki Kashiwagi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige
  Internal Medicine.2020; 59(19): 2343.     CrossRef
• Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab
  Zhe Yan, Bei-Bei Cui, Yong-Yang Yu, Geng Yin, Xiao-Min Cen, Qi-Bing Xie
  Medicine.2019; 98(9): e14624.     CrossRef
• Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet’s disease
  Naomi Sugimura, Tsutomu Mizoshita, Tomoya Sugiyama, Shozo Togawa, Tomokatsu Miyaki, Taketo Suzuki, Satoshi Tanida, Hiromi Kataoka, Makoto Sasaki
  Digestive and Liver Disease.2019; 51(7): 967.     CrossRef
• Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
  Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Shingo Nakayamada, Kazuyoshi Saito, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Akio Kawabe, Yusuke Miyazaki, Yoshiya Tanaka
  Arthritis Research & Therapy.2019;[Epub]     CrossRef
• Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet’s disease in Taiwan
  Ya-Chiao Hu, Yao-Hsu Yang, Yu-Tsan Lin, Li-Chieh Wang, Hsin-Hui Yu, Jyh-Hong Lee, Bor-Luen Chiang
  BMC Pediatrics.2019;[Epub]     CrossRef
• Management of Behçet's disease
  Fatma Alibaz-Oner, Amr H. Sawalha, Haner Direskeneli
  Current Opinion in Rheumatology.2018; 30(3): 238.     CrossRef
• Updated treatment strategies for intestinal Behçet’s disease
  Yong Eun Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2018; 33(1): 1.     CrossRef
• Gastrointestinal Involvement in Behçet Disease
  Ibrahim Hatemi, Gulen Hatemi, Aykut Ferhat Çelik
  Rheumatic Disease Clinics of North America.2018; 44(1): 45.     CrossRef
• Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
  Jihye Park, Jae Hee Cheon
  Gut and Liver.2018; 12(6): 623.     CrossRef
• Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
  Jihye Park, Jae Hee Cheon
  Intestinal Research.2017; 15(3): 263.     CrossRef

Citations

Citations to this article as recorded by  

• Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis
  Charles Muller, Akihiro Yamada, Sachie Ikegami, Haider Haider, Yuga Komaki, Fukiko Komaki, Dejan Micic, Atsushi Sakuraba
  Clinical Gastroenterology and Hepatology.2022; 20(3): 622.     CrossRef
• Synchronized early gastric cancer occurred in a patient with serrated polyposis syndrome: A case report
  Ying-Ze Ning, Guan-Yi Liu, Xiao-Long Rao, Yong-Chen Ma, Long Rong
  World Journal of Clinical Cases.2022; 10(8): 2644.     CrossRef
• Usefulness of narrow-band imaging for the detection of remnant sessile-serrated adenoma (SSA) tissue after endoscopic resection: the KASID multicenter study
  Yunho Jung, Jung Rock Moon, Seong Ran Jeon, Jae Myung Cha, Hyo-Joon Yang, Suyeon Park, Yumi Ahn, Jeong-Sik Byeon, Hyun Gun Kim
  Surgical Endoscopy.2021; 35(9): 5217.     CrossRef
• Serrated Polyposis Syndrome with a Synchronous Colon Adenocarcinoma Treated by an Endoscopic Mucosal Resection
  Sang Hoon Lee, Sung Joon Lee, Sung Chul Park, Seung-Joo Nam, Myeong Ho Kang, Tae Suk Kim, Seung Koo Lee
  The Korean Journal of Gastroenterology.2020; 76(3): 159.     CrossRef

Citations

Citations to this article as recorded by  

• Future Implications of Artificial Intelligence in Medical Education
  Forrest Bohler, Nikhil Aggarwal, Garrett Peters, Varna Taranikanti
  Cureus.2024;[Epub]     CrossRef
• Polyp Segmentation Using a Hybrid Vision Transformer and a Hybrid Loss Function
  Evgin Goceri
  Journal of Imaging Informatics in Medicine.2024; 37(2): 851.     CrossRef
• SAEFormer: stepwise attention emphasis transformer for polyp segmentation
  Yicai Tan, Lei Chen, Chudong Zheng, Hui Ling, Xinshan Lai
  Multimedia Tools and Applications.2024;[Epub]     CrossRef
• Polyp Segmentation With the FCB-SwinV2 Transformer
  Kerr Fitzgerald, Jorge Bernal, Aymeric Histace, Bogdan J. Matuszewski
  IEEE Access.2024; 12: 38927.     CrossRef
• Leveraging a realistic synthetic database to learn Shape-from-Shading for estimating the colon depth in colonoscopy images
  Josué Ruano, Martín Gómez, Eduardo Romero, Antoine Manzanera
  Computerized Medical Imaging and Graphics.2024; 115: 102390.     CrossRef
• DHAFormer: Dual-channel hybrid attention network with transformer for polyp segmentation
  Xuejie Huang, Liejun Wang, Shaochen Jiang, Lianghui Xu, Chung-Ming Lo
  PLOS ONE.2024; 19(7): e0306596.     CrossRef
• The Findings of Index Colonoscopy in Patients with Post-colonoscopy Colorectal Cancer (PCCRC)
  Seiji Kimura
  Nihon Daicho Komonbyo Gakkai Zasshi.2024; 77(8): 457.     CrossRef
• Detection of various gastrointestinal tract diseases through a deep learning method with ensemble ELM and explainable AI
  Md. Faysal Ahamed, Md. Nahiduzzaman, Md. Rabiul Islam, Mansura Naznine, Mohamed Arselene Ayari, Amith Khandakar, Julfikar Haider
  Expert Systems with Applications.2024; 256: 124908.     CrossRef
• A Hessian-Based Technique for Specular Reflection Detection and Inpainting in Colonoscopy Images
  Khaled ELKarazle, Valliappan Raman, Caslon Chua, Patrick Then
  IEEE Journal of Biomedical and Health Informatics.2024; 28(8): 4724.     CrossRef
• Trends in colorectal cancer surgical resection rates during the screening era: a retrospective study in Italy
  Manuel Zorzi, Lucia Calciano, Nicola Gennaro, Laura Memo, Silvia Rizzato, Carmen Stocco, Emanuele D L Urso, Silvia Negro, Gaya Spolverato, Salvatore Pucciarelli, Marta Sbaraglia, Stefano Guzzinati
  BMJ Open Gastroenterology.2024; 11(1): e001434.     CrossRef
• The Interplay among Wnt/β-catenin Family Members in Colorectal Adenomas and Surrounding Tissues
  Domenica Lucia D’Antonio, Fabiana Fantini, Carmelo Moscatello, Alessio Ferrone, Stefano Scaringi, Rosa Valanzano, Ferdinando Ficari, Konstantinos Efthymakis, Matteo Neri, Gitana Maria Aceto, Maria Cristina Curia
  Biomedicines.2024; 12(8): 1730.     CrossRef
• Review: Risk assessment of liver and biliary cancer mortality through detection of high risk polyps at colonoscopies
  Abeera Tariq, Fnu Hafeezullah, Abdul Basit Khan
  Digestive and Liver Disease.2024;[Epub]     CrossRef
• An ensemble framework of deep neural networks for colorectal polyp classification
  Farah Younas, Muhammad Usman, Wei Qi Yan
  Multimedia Tools and Applications.2023; 82(12): 18925.     CrossRef
• Effect of computer‐aided colonoscopy on adenoma miss rates and polyp detection: A systematic review and meta‐analysis
  Sagar Shah, Nathan Park, Nabil El Hage Chehade, Anastasia Chahine, Marc Monachese, Amelie Tiritilli, Zain Moosvi, Ronald Ortizo, Jason Samarasena
  Journal of Gastroenterology and Hepatology.2023; 38(2): 162.     CrossRef
• Comparison of missed adenomas in deep-sedated and unsedated colonoscopy: A multicenter retrospective study
  Yue Sui, Yanhua Zheng, Qing Wang, Jieping Lv, Hongjin Wang, Qing Wen, Zhenzhen Wang, Guanfeng Wang, Hui Jia, Fengzhen Cao, Naping Wang, Junlian Hao, Yiping Zhang, Xiaopeng Wu, Haihua Chen, Junhui Lu, Xing Chen
  European Journal of Internal Medicine.2023; 110: 48.     CrossRef
• A Real-Time Polyp-Detection System with Clinical Application in Colonoscopy Using Deep Convolutional Neural Networks
  Adrian Krenzer, Michael Banck, Kevin Makowski, Amar Hekalo, Daniel Fitting, Joel Troya, Boban Sudarevic, Wolfgang G. Zoller, Alexander Hann, Frank Puppe
  Journal of Imaging.2023; 9(2): 26.     CrossRef
• Robust real-time polyp detection system design based on YOLO algorithms by optimizing activation functions and hyper-parameters with artificial bee colony (ABC)
  Ahmet Karaman, Ishak Pacal, Alper Basturk, Bahriye Akay, Ufuk Nalbantoglu, Seymanur Coskun, Omur Sahin, Dervis Karaboga
  Expert Systems with Applications.2023; 221: 119741.     CrossRef
• Efficient Gastrointestinal Disease Classification Using Pretrained Deep Convolutional Neural Network
  Muhammad Nouman Noor, Muhammad Nazir, Sajid Ali Khan, Oh-Young Song, Imran Ashraf
  Electronics.2023; 12(7): 1557.     CrossRef
• The basis and implications of diverging approaches to colorectal adenoma surveillance in the West
  Tsai‐Wing Ow, Edmund Tse, Guru Iyngkaran, Finlay Macrae
  Internal Medicine Journal.2023; 53(4): 635.     CrossRef
• Investigation of artificial intelligence integrated fluorescence endoscopy image analysis with indocyanine green for interpretation of precancerous lesions in colon cancer
  Jinhyeon Kim, Hajung Kim, Yong Sik Yoon, Chan Wook Kim, Seung-Mo Hong, Sungjee Kim, Doowon Choi, Jihyun Chun, Seung Wook Hong, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang, Sun Young Kim, Seung-Jae Myung,
  PLOS ONE.2023; 18(5): e0286189.     CrossRef
• Linked color imaging versus conventional white light colonoscopy for the detection of colorectal polyps
  Jun Watanabe, Takeshi Kanno, Eiichi Kakehi, Kazuma Rifu, Takehiro Kagaya, Kazuhiko Kotani, Yuki Kataoka
  Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef
• A dynamic loss function for improved semantic segmentation
  Haroon Haider Khan, Majid Iqbal Khan
  Soft Computing.2023;[Epub]     CrossRef
• Improved Colorectal Polyp Segmentation Using Enhanced MA-NET and Modified Mix-ViT Transformer
  Khaled Elkarazle, Valliappan Raman, Patrick Then, Caslon Chua
  IEEE Access.2023; 11: 69295.     CrossRef
• Localization and Classification of Gastrointestinal Tract Disorders Using Explainable AI from Endoscopic Images
  Muhammad Nouman Noor, Muhammad Nazir, Sajid Ali Khan, Imran Ashraf, Oh-Young Song
  Applied Sciences.2023; 13(15): 9031.     CrossRef
• Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
  Xiaoli Wu, Chun-Wei Chen, Sangeeta Jaiswal, Tse-Shao Chang, Ruoliu Zhang, Michael K. Dame, Yuting Duan, Hui Jiang, Jason R. Spence, Sen-Yung Hsieh, Thomas D. Wang
  Cancers.2023; 15(19): 4795.     CrossRef
• Comparative Analysis of Machine Learning Models for Image Detection of Colonic Polyps vs. Resected Polyps
  Adriel Abraham, Rejath Jose, Jawad Ahmad, Jai Joshi, Thomas Jacob, Aziz-ur-rahman Khalid, Hassam Ali, Pratik Patel, Jaspreet Singh, Milan Toma
  Journal of Imaging.2023; 9(10): 215.     CrossRef
• Additional 30-Second Observation of the Right-Sided Colon for Missed Polyp Detection With Texture and Color Enhancement Imaging Compared with Narrow Band Imaging: A Randomized Trial
  Naohisa Yoshida, Yoshikazu Inagaki, Yutaka Inada, Reo Kobayashi, Yuri Tomita, Hikaru Hashimoto, Osamu Dohi, Ryohei Hirose, Ken Inoue, Takaaki Murakami, Yasutaka Morimoto, Yusuke Okuyama, Yukiko Morinaga, Yoshito Itoh
  American Journal of Gastroenterology.2023;[Epub]     CrossRef
• Wide-field endoscope accessory for multiplexed fluorescence imaging
  Gaoming Li, Miki Lee, Tse-Shao Chang, Joonyoung Yu, Haijun Li, Xiyu Duan, Xiaoli Wu, Sangeeta Jaiswal, Shuo Feng, Kenn R. Oldham, Thomas D. Wang
  Scientific Reports.2023;[Epub]     CrossRef
• Analysis and research on intelligent manufacturing medical product design and intelligent hospital system dynamics based on machine learning under big data
  Zongxin Liu, Jiaozi Pu
  Enterprise Information Systems.2022; 16(2): 193.     CrossRef
• Application of multimedia network english listening model based on confidence learning algorithm for speech recognition
  Yingting Zhang, Zewei Huang
  International Journal of System Assurance Engineering and Management.2022; 13(S3): 1091.     CrossRef
• Unified Focal loss: Generalising Dice and cross entropy-based losses to handle class imbalanced medical image segmentation
  Michael Yeung, Evis Sala, Carola-Bibiane Schönlieb, Leonardo Rundo
  Computerized Medical Imaging and Graphics.2022; 95: 102026.     CrossRef
• Colonoscopic image synthesis with generative adversarial network for enhanced detection of sessile serrated lesions using convolutional neural network
  Dan Yoon, Hyoun-Joong Kong, Byeong Soo Kim, Woo Sang Cho, Jung Chan Lee, Minwoo Cho, Min Hyuk Lim, Sun Young Yang, Seon Hee Lim, Jooyoung Lee, Ji Hyun Song, Goh Eun Chung, Ji Min Choi, Hae Yeon Kang, Jung Ho Bae, Sungwan Kim
  Scientific Reports.2022;[Epub]     CrossRef
• Endo‐wing versus transparent hood‐assisted colonoscopy for colorectal adenoma detection: A randomized controlled trial
  Kazuya Miyaguchi, Yoshikazu Tsuzuki, Nobutaka Hirooka, Rie Shiomi, Hideki Ohgo, Hidetomo Nakamoto, Hiroyuki Imaeda
  Journal of Gastroenterology and Hepatology.2022; 37(4): 766.     CrossRef
• AI and Clinical Decision Making: The Limitations and Risks of Computational Reductionism in Bowel Cancer Screening
  Saleem Ameen, Ming-Chao Wong, Kwang-Chien Yee, Paul Turner
  Applied Sciences.2022; 12(7): 3341.     CrossRef
• BlazeNeo: Blazing Fast Polyp Segmentation and Neoplasm Detection
  Nguyen S. An, Phan N. Lan, Dao V. Hang, Dao V. Long, Tran Q. Trung, Nguyen T. Thuy, Dinh V. Sang
  IEEE Access.2022; 10: 43669.     CrossRef
• Establishment and evaluation of a nomogram predicting risks of missed diagnoses of colorectal polyps
  Xiaobo Wang, Haiyang Guo, Yong Tang, Lin Chen, Xianfei Wang
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Evaluation of the efficacy of 1 L polyethylene glycol plus ascorbic acid and an oral sodium sulfate solution: A multi-center, prospective randomized controlled trial
  Jung Hun Woo, Hoon Sup Koo, Dae Sung Kim, Jeong Eun Shin, Yunho Jung, Kyu Chan Huh
  Medicine.2022; 101(35): e30355.     CrossRef
• Correlation between Surrogate Quality Indicators for Adenoma Detection Rate and Adenoma Miss Rate in Qualified Colonoscopy, CORE Study: KASID Multicenter Study
  Jae Hee Han, Hyun Gun Kim, Eu Mi Ahn, Suyeon Park, Seong Ran Jeon, Jae Myung Cha, Min Seob Kwak, Yunho Jung, Jeong Eun Shin, Hyun Deok Shin, Young-Seok Cho
  Gut and Liver.2022; 16(5): 716.     CrossRef
• Endoscopy Lifetime Systems Architecture: Scoping Out the Past to Diagnose the Future Technology
  Craig M. Browning, Robert Cloutier, Thomas C. Rich, Silas J. Leavesley
  Systems.2022; 10(5): 189.     CrossRef
• A stacking-based artificial intelligence framework for an effective detection and localization of colon polyps
  Carina Albuquerque, Roberto Henriques, Mauro Castelli
  Scientific Reports.2022;[Epub]     CrossRef
• Effect of water exchange method on adenoma miss rate of patients undergoing selective polypectomy: A randomized controlled trial
  Gui Ren, Xiangping Wang, Hui Luo, Shaowei Yao, Shuhui Liang, Linhui Zhang, Tao Dong, Long Chen, Qin Tao, Xuegang Guo, Ying Han, Yanglin Pan
  Digestive and Liver Disease.2021; 53(5): 625.     CrossRef
• Feature Point Tracking-Based Localization of Colon Capsule Endoscope
  Jürgen Herp, Ulrik Deding, Maria M. Buijs, Rasmus Kroijer, Gunnar Baatrup, Esmaeil S. Nadimi
  Diagnostics.2021; 11(2): 193.     CrossRef
• Risk factors associated with missed colorectal lesions in colonoscopy and impact of colonoscopy with anesthesia on miss rate
  Haibin Dong, Yutang Ren, Bo Jiang
  Scandinavian Journal of Gastroenterology.2021; 56(4): 484.     CrossRef
• Diagnostic Accuracy of Artificial Intelligence and Computer-Aided Diagnosis for the Detection and Characterization of Colorectal Polyps: Systematic Review and Meta-analysis
  Scarlet Nazarian, Ben Glover, Hutan Ashrafian, Ara Darzi, Julian Teare
  Journal of Medical Internet Research.2021; 23(7): e27370.     CrossRef
• Focus U-Net: A novel dual attention-gated CNN for polyp segmentation during colonoscopy
  Michael Yeung, Evis Sala, Carola-Bibiane Schönlieb, Leonardo Rundo
  Computers in Biology and Medicine.2021; 137: 104815.     CrossRef
• Comparison of adenoma detection by colonoscopy between polypectomy performed during both insertion and withdrawal versus during withdrawal only: a multicenter, randomized, controlled trial
  Tae-Geun Gweon, Seung-Woo Lee, Jeong-Seon Ji, Jeong Rok Lee, Joon Sung Kim, Byung-Wook Kim, Hwang Choi
  Surgical Endoscopy.2020; 34(12): 5461.     CrossRef
• Water Exchange (WE) and Quality Improvement—Enhanced Advanced Adenoma Detection
  Felix W. Leung, Malcolm Koo, Hui Jia, Joseph W. Leung, Sergio Cadoni, Premysl Falt, Yu-Hsi Hsieh, Chi-Tan Hu, Yanglin Pan, Franco Radaelli
  Journal of Clinical Gastroenterology.2020; 54(3): 212.     CrossRef
• Tubular Locomotion and Positioning Using Tip Eversion for Endoscopy
  Ankit Saxena, Eric M. Pauli, Randy S. Haluck, Barry Fell, Jason Moore
  Journal of Medical Devices.2020;[Epub]     CrossRef
• Molecular Aspects of Colorectal Adenomas: The Interplay among Microenvironment, Oxidative Stress, and Predisposition
  Gitana Maria Aceto, Teresa Catalano, Maria Cristina Curia
  BioMed Research International.2020; 2020: 1.     CrossRef
• Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
  Tobias Niedermaier, Efrat L. Amitay, Anton Gies, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner
  Clinical and Translational Gastroenterology.2020; 11(4): e00169.     CrossRef
• Polyp Segmentation with Fully Convolutional Deep Neural Networks—Extended Evaluation Study
  Yunbo Guo, Jorge Bernal, Bogdan J. Matuszewski
  Journal of Imaging.2020; 6(7): 69.     CrossRef
• A comprehensive review of deep learning in colon cancer
  Ishak Pacal, Dervis Karaboga, Alper Basturk, Bahriye Akay, Ufuk Nalbantoglu
  Computers in Biology and Medicine.2020; 126: 104003.     CrossRef
• Artificial intelligence technologies for the detection of colorectal lesions: The future is now
  Simona Attardo, Viveksandeep Thoguluva Chandrasekar, Marco Spadaccini, Roberta Maselli, Harsh K Patel, Madhav Desai, Antonio Capogreco, Matteo Badalamenti, Piera Alessia Galtieri, Gaia Pellegatta, Alessandro Fugazza, Silvia Carrara, Andrea Anderloni, Piet
  World Journal of Gastroenterology.2020; 26(37): 5606.     CrossRef
• Training a computer-aided polyp detection system to detect sessile serrated adenomas using public domain colonoscopy videos
  Taibo Li, Jeremy R. Glissen Brown, Kelovoulos Tsourides, Nadim Mahmud, Jonah M. Cohen, Tyler M. Berzin
  Endoscopy International Open.2020; 08(10): E1448.     CrossRef
• PICCOLO White-Light and Narrow-Band Imaging Colonoscopic Dataset: A Performance Comparative of Models and Datasets
  Luisa F. Sánchez-Peralta, J. Blas Pagador, Artzai Picón, Ángel José Calderón, Francisco Polo, Nagore Andraka, Roberto Bilbao, Ben Glover, Cristina L. Saratxaga, Francisco M. Sánchez-Margallo
  Applied Sciences.2020; 10(23): 8501.     CrossRef
• Efficacy of 1.2 L polyethylene glycol plus ascorbic acid for bowel preparations
  Hiroyuki Tamaki, Teruyo Noda, Masahiro Morita, Akina Omura, Atsushi Kubo, Chikara Ogawa, Toshihiro Matsunaka, Mitsushige Shibatoge
  World Journal of Clinical Cases.2019; 7(4): 452.     CrossRef
• Multimodal endoscopic system based on multispectral and photometric stereo imaging and analysis
  Jihun Kim, Hasan Al Faruque, Sewoong Kim, Eunjoo Kim, Jae Youn Hwang
  Biomedical Optics Express.2019; 10(5): 2289.     CrossRef
• Blue Laser Imaging, Blue Light Imaging, and Linked Color Imaging for the Detection and Characterization of Colorectal Tumors
  Naohisa Yoshida, Osamu Dohi, Ken Inoue, Ritsu Yasuda, Takaaki Murakami, Ryohei Hirose, Ken Inoue, Yuji Naito, Yutaka Inada, Kiyoshi Ogiso, Yukiko Morinaga, Mitsuo Kishimoto, Rafiz Abdul Rani, Yoshito Itoh
  Gut and Liver.2019; 13(2): 140.     CrossRef
• Application of OCT in the Gastrointestinal Tract
  Nicholas S. Samel, Hiroshi Mashimo
  Applied Sciences.2019; 9(15): 2991.     CrossRef
• Near-Infrared Fluorescent Activated Polymeric Probe for Imaging Intraluminal Colorectal Cancer Tumors
  Eva Kopansky-Groisman, Inga Kogan-Zviagin, Osnat Sella-Tavor, Mor Oron-Herman, Ayelet David
  Biomacromolecules.2019; 20(9): 3547.     CrossRef
• Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: A KASID multicenter study
  Ji Young Chang, Chang Mo Moon, Hyun Jung Lee, Hyo-Joon Yang, Yunho Jung, Sang Wook Kim, Sung-Ae Jung, Jeong-Sik Byeon, Frank T. Kolligs
  PLOS ONE.2018; 13(4): e0195709.     CrossRef
• Cimetropium bromide does not improve polyp and adenoma detection during colonoscope withdrawal
  Peel Jung, Su B. Park, Hyung W. Kim, Dae H. Kang, Cheol W. Choi, Su J. Kim, Hyeong S. Nam, Dae G. Ryu, Joung B. Hong, Dong J. Kim
  Medicine.2018; 97(25): e11253.     CrossRef
• Dielectric properties of colon polyps, cancer, and normal mucosa: Ex vivo measurements from 0.5 to 20 GHz
  Marta Guardiola, Santiago Buitrago, Glòria Fernández‐Esparrach, Joan M. O'Callaghan, Jordi Romeu, Miriam Cuatrecasas, Henry Córdova, Miguel Ángel González Ballester, Oscar Camara
  Medical Physics.2018; 45(8): 3768.     CrossRef
• Quality is the key for emerging issues of population-based colonoscopy screening
  Jin Young Yoon, Jae Myung Cha, Yoon Tae Jeen
  Intestinal Research.2018; 16(1): 48.     CrossRef
• An Additional 30-s Observation of the Right-Sided Colon with Narrow Band Imaging Decreases Missed Polyps: A Pilot Study
  Naohisa Yoshida, Ken Inoue, Ritsu Yasuda, Ryohei Hirose, Osamu Dohi, Yuji Naito, Takaaki Murakami, Yutaka Inada, Kiyoshi Ogiso, Yukiko Morinaga, Mitsuo Kishimoto, Rafiz Abdul Rani, Yoshito Itoh
  Digestive Diseases and Sciences.2018; 63(12): 3457.     CrossRef
• Quality is the Key for Emerging Issues of Population-Based Colonoscopy Screening
  Jin Young Yoon, Jae Myung Cha, Yoon Tae Jeen
  Clinical Endoscopy.2018; 51(1): 50.     CrossRef
• Additional Thirty Seconds Observation with Linked Color Imaging Improves Detection of Missed Polyps in the Right-Sided Colon
  Naohisa Yoshida, Yutaka Inada, Ritsu Yasuda, Takaaki Murakami, Ryohei Hirose, Ken Inoue, Osamu Dohi, Yuji Naito, Kiyoshi Ogiso, Yukiko Morinaga, Mitsuo Kishimoto, Eiichi Konishi, Yoshito Itoh
  Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
• Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted Protein-2 (CCSP-2)
  Jaeil Kim, Eun-ju Do, Helen Moinova, Sang Mun Bae, Ja Young Kang, Seung-Mo Hong, Stephen P. Fink, Jinmyoung Joo, Young-Ah Suh, Se Jin Jang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Jaewon Choe, Suk-Kyun Yang, Sanfo
  Neoplasia.2017; 19(10): 805.     CrossRef

Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the class of “sartans” remains to be clarified. A 45-year-old woman with chronic kidney disease along with hypothyroidism and hypertension presented with chronic diarrhea and significant weight loss. Endoscopy of the upper gastrointestinal tract showed scalloping and grooving of the duodenum, and histopathological examination showed subtotal villous atrophy. She was on telmisartan for hypertension, which was discontinued. Subsequently, diarrhea ameliorated dramatically, and she regained weight. To our knowledge, this is the first study to report telmisartan-associated sprue-like enteropathy. Further, we have reviewed the cases of patients with sprue-like enteropathy caused by valsartan, irbesartan, and eprosartan.

Citations

Citations to this article as recorded by  

• Olmesartan induced gastritis and enteropathy
  Ankur Gupta, Priyanka Jain, Latika Gupta
  Indian Journal of Gastroenterology.2024; 43(3): 684.     CrossRef
• Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
  Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, Stiliano Maimaris, Giovanni Arpa, Federico Biagi, David S. Sanders
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 432.     CrossRef
• Olmesartan induced enteropathy affecting the entire gastrointestinal tract: a case report
  N Van Horebeek, R Croes, A Vonck, E Colpaert
  Acta Gastro Enterologica Belgica.2023; 86(1): 95.     CrossRef
• A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
  Seo Yeon Yoo, Jihun Kim, Kee Wook Jung
  Journal of Neurogastroenterology and Motility.2022; 28(2): 327.     CrossRef
• The histological spectrum of ARB‐induced gastritis
  Tanner Storozuk, Ian Brown, Stephen Lagana, Maria Westerhoff, Namrata Setia, John Hart, Lindsay Alpert
  Histopathology.2022; 81(5): 653.     CrossRef
• Severe cases of sprue‐like enteropathy associated with angiotensin receptor blockers other than olmesartan
  Peter Malfertheiner, Chiara Formigoni
  GastroHep.2021; 3(2): 88.     CrossRef
• Telmisartan-induced sprue-like enteropathy: a case report
  Natalia Alzueta, Amaya Echeverría, Lorea Sanz, Carmen Fontela, Teresa Acín, Lidia Montenegro, Javier Garjón
  European Journal of Hospital Pharmacy.2020; 27(1): 49.     CrossRef
• Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture
  Francesco Abbruzzi, Ilaria Loconte, Sonia Carparelli, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi
  Current Drug Safety.2020; 15(1): 65.     CrossRef
• Traitement par olmésartan et entéropathie : à propos de deux cas et revue de la littérature
  A. Sadki, M. Le Besnerais, F. Héron, I. Marie
  La Revue de Médecine Interne.2019; 40(2): 112.     CrossRef
• A simple treatment for a potentially life-threatening cause of malabsorption
  Mattia Bonzi, Elisa M. Fiorelli, Gaia Montanelli, Ludovico Furlan, Monica Solbiati
  Internal and Emergency Medicine.2019; 14(6): 967.     CrossRef
• Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
  Ayesha Kamal, Christopher Fain, Angela Park, Peiqi Wang, Eduardo Gonzalez-Velez, Daniel A Leffler, Susan M Hutfless
  Gastroenterology Report.2019; 7(3): 162.     CrossRef
• Association of sprue-like enteropathy and angiotensin receptor-1 antagonists
  René R. Wenzel, Christian Datz
  Wiener klinische Wochenschrift.2019; 131(19-20): 493.     CrossRef
• Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
  Peter Malfertheiner, Claudio Ripellino, Nazarena Cataldo
  Pharmacoepidemiology and Drug Safety.2018; 27(6): 581.     CrossRef

We report the case of a 5-year-old male patient with multiple aseptic splenic abscesses associated with Behçet's disease. The patient visited Gachon University Gil Hospital with fever, abdominal pain, and acute watery and bloody diarrhea, and reported a 2-year history of chronic abdominal pain and intermittent watery diarrhea. He was treated with antibiotics at a local clinic for fever and cervical lymph node swelling. Additionally, he had recurrent stomatitis. A colonoscopy showed multiple well-demarcated ulcerations throughout the colon, and abdominal computed tomography showed multiple splenic abscesses. Pathergy and HLA-B51 tests were positive. Investigations did not reveal any infectious organisms in the aspirate obtained via ultrasound-guided fine needle aspiration. After steroid treatment, all symptoms and multiple aseptic splenic abscesses resolved. However, oral ulcers, genital ulcers, and abdominal pain recurred after tapering the steroids. Infliximab treatment improved the patient's symptoms. However, 5 months after the treatment, the symptoms recurred. The treatment was changed to include adalimumab. Subsequently, the patient's symptoms resolved and colonoscopic findings improved. No recurrence was noted after 3 months of follow-up.

Citations

Citations to this article as recorded by  

• Aseptic Abscess of the Spleen as an Antecedent Manifestation of Behçet’s Disease
  Mohamed Jazeer, Diroji Antony, Mayurathan Pakkiyaretnam
  Cureus.2023;[Epub]     CrossRef
• Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data
  Ezgi Deniz Batu, Seher Sener, Veysel Cam, Nuray Aktay Ayaz, Seza Ozen
  BioDrugs.2023; 37(6): 813.     CrossRef
• Case report: Aseptic splenic abscesses in childhood-onset systemic lupus erythematosus
  Shobashenee Sritharan, Peter Sie-Teck Lau, Kamilah Manan, Anand Mohan
  Frontiers in Pediatrics.2023;[Epub]     CrossRef
• Successful management of a case of intestinal Behçet’s disease with a splenic abscess by intensified immunosuppressive therapy without splenectomy
  Noriko Sato, Fumiya Yamaide, Ryohei Shibata, Taiji Nakano, Akiko Yamaide, Takeshi Saito, Naoki Shimojo
  Modern Rheumatology Case Reports.2022; 6(2): 266.     CrossRef
• Adalimumab in the treatment of pediatric Behçet’s disease: case-based review
  Dimitri Poddighe, Zaure Mukusheva, Kaisar Dauyey, Maikesh Assylbekova
  Rheumatology International.2019; 39(6): 1107.     CrossRef